K+S Aktiengesellschaft

LSE:0Q2N Stock Report

Market Cap: €2.0b

K+S Valuation

Is 0Q2N undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0Q2N when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0Q2N (€11.34) is trading above our estimate of fair value (€1.43)

Significantly Below Fair Value: 0Q2N is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0Q2N?

Key metric: As 0Q2N is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0Q2N. This is calculated by dividing 0Q2N's market cap by their current earnings.
What is 0Q2N's PE Ratio?
PE Ratio78.9x
Earnings€25.60m
Market Cap€2.02b

Price to Earnings Ratio vs Peers

How does 0Q2N's PE Ratio compare to its peers?

The above table shows the PE ratio for 0Q2N vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.7x
JMAT Johnson Matthey
23.8x28.4%UK£2.6b
VCT Victrex
24.9x37.8%UK£763.5m
CEY Centamin
25.5x21.7%UK£1.7b
BREE Breedon Group
16.8x14.1%UK£1.6b
0Q2N K+S
78.9x61.1%€2.0b

Price-To-Earnings vs Peers: 0Q2N is expensive based on its Price-To-Earnings Ratio (78.9x) compared to the peer average (22.7x).

Price to Earnings Ratio vs Industry

How does 0Q2N's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0Q2N 78.9xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0Q2N is expensive based on its Price-To-Earnings Ratio (78.9x) compared to the European Chemicals industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is 0Q2N's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0Q2N PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio78.9x
Fair PE Ratio38x

Price-To-Earnings vs Fair Ratio: 0Q2N is expensive based on its Price-To-Earnings Ratio (78.9x) compared to the estimated Fair Price-To-Earnings Ratio (38x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0Q2N forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€11.34
€11.48
+1.3%
25.1%€17.50€7.50n/a16
Nov ’25€11.19
€12.40
+10.8%
25.5%€18.00€7.50n/a17
Oct ’25€11.50
€13.14
+14.3%
25.1%€19.00€7.50n/a17
Sep ’25€10.74
€13.42
+25.0%
25.3%€19.00€7.50n/a17
Aug ’25€11.88
€14.61
+23.0%
20.8%€20.00€10.00n/a17
Jul ’25€12.51
€15.24
+21.8%
18.2%€20.00€10.00n/a17
Jun ’25€13.53
€15.31
+13.1%
17.5%€20.00€10.00n/a17
May ’25€14.11
€15.46
+9.6%
17.2%€20.00€10.00n/a17
Apr ’25€14.58
€15.55
+6.6%
16.9%€20.00€10.00n/a16
Mar ’25€13.08
€16.69
+27.6%
20.6%€23.00€11.00n/a16
Feb ’25€12.77
€16.69
+30.7%
20.6%€23.00€11.00n/a16
Jan ’25€14.24
€18.01
+26.5%
17.1%€23.00€13.00n/a16
Dec ’24€13.50
€18.21
+34.9%
15.7%€23.00€13.00n/a16
Nov ’24€15.64
€19.45
+24.4%
15.7%€25.00€16.00€11.1916
Oct ’24€17.35
€19.64
+13.2%
16.3%€25.00€15.00€11.5016
Sep ’24€17.51
€19.64
+12.2%
16.3%€25.00€15.00€10.7416
Aug ’24€17.26
€19.18
+11.1%
15.9%€25.00€15.00€11.8816
Jul ’24€15.95
€20.07
+25.8%
15.8%€26.00€16.00€12.5116
Jun ’24€15.03
€20.76
+38.2%
17.6%€27.00€16.70€13.5316
May ’24€18.09
€23.58
+30.3%
17.2%€30.00€17.00€14.1116
Apr ’24€19.68
€24.09
+22.4%
15.7%€30.00€17.00€14.5816
Mar ’24€22.71
€25.13
+10.6%
15.7%€35.00€19.90€13.0815
Feb ’24€21.53
€25.26
+17.3%
16.0%€35.00€19.90€12.7715
Jan ’24€18.35
€25.89
+41.1%
15.2%€35.00€20.30€14.2415
Dec ’23€20.78
€25.59
+23.2%
15.3%€35.00€20.30€13.5014
Nov ’23€22.66
€27.47
+21.2%
19.8%€38.00€21.00€15.6415

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Elkem

NOK 11.6b

Engages in the provision of advanced material solutions worldwide.

0SFN

NOK 18.05

7D

0.6%

1Y

-0.6%

Navigator Company

€2.5b

Manufactures and markets pulp and paper products worldwide.

0KLO

€3.53

7D

-2.7%

1Y

-6.7%

NV Bekaert

€1.7b

Provides steel wire transformation and coating technologies worldwide.

0OQJ

€32.30

7D

-1.0%

1Y

-22.3%